New insights on the viral and host factors contributing to the airway pathogenesis caused by the respiratory syncytial virus

References

• Aberle JH, Aberle SW, Dworzak MN, et al. (1999). Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am J Respir Crit Care Med 160:1263–8
   PubMed Web of Science ®Google Scholar
• Abu-Harb M, Bell F, Finn A, et al. (1999). IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis. Eur Respir J 14:139–43
   PubMed Web of Science ®Google Scholar
• Adamko DJ, Friesen M. (2012). Why does respiratory syncytial virus appear to cause asthma? J Allergy Clin Immunol 130:101–2
   PubMed Web of Science ®Google Scholar
• Aherne W, Bird T, Court SD, et al. (1970). Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 23:7–18
   PubMed Web of Science ®Google Scholar
• Ajuebor MN, Flower RJ, Hannon R, et al. (1998). Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model. J Leukoc Biol 63:108–16
   PubMed Web of Science ®Google Scholar
• Arnold R, Konig W. (2005). Respiratory syncytial virus infection of human lung endothelial cells enhances selectively intercellular adhesion molecule-1 expression. J Immunol 174:7359–67
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Walz A, Kunkel SL. (1989). Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045–9
   PubMed Web of Science ®Google Scholar
• Bardach A, Rey-Ares L, Cafferata ML, et al. (2014). Systematic review and meta-analysis of respiratory syncytial virus infection epidemiology in Latin America. Rev Med Virol 24:76–89
   PubMed Web of Science ®Google Scholar
• Baum A, Garcia-Sastre A. (2010). Induction of type I interferon by RNA viruses: cellular receptors and their substrates. Amino Acids 38:1283–99
   PubMed Web of Science ®Google Scholar
• Beale J, Jayaraman A, Jackson DJ, et al. (2014). Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Transl Med 6:256ra134
   PubMed Web of Science ®Google Scholar
• Bermejo-Martin JF, Garcia-Arevalo MC, De Lejarazu RO, et al. (2007). Predominance of Th2 cytokines, CXC chemokines and innate immunity mediators at the mucosal level during severe respiratory syncytial virus infection in children. Eur Cytokine Netw 18:162–7
   PubMed Web of Science ®Google Scholar
• Bonecchi R, Bianchi G, Bordignon PP, et al. (1998). Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129–34
   PubMed Web of Science ®Google Scholar
• Bont L, Heijnen CJ, Kavelaars A, et al. (1999). Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis. Eur Respir J 14:144–9
   PubMed Web of Science ®Google Scholar
• Bose S, Basu M, Banerjee AK. (2004). Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells. J Virol 78:8146–58
   PubMed Web of Science ®Google Scholar
• Boyoglu-Barnum S, Gaston KA, Todd SO, et al. (2013). A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice. J Virol 87:10955–67
   PubMed Web of Science ®Google Scholar
• Breindahl M. (2012). Cytokine responses in infants infected with respiratory syncytial virus. Open J Immunol 2:40–8
   Google Scholar
• Bueno SM, Gonzalez PA, Cautivo KM, et al. (2008a). Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc Natl Acad Sci USA 105:20822–7
   PubMed Web of Science ®Google Scholar
• Bueno SM, Gonzalez PA, Pacheco R, et al. (2008b). Host immunity during RSV pathogenesis. Int Immunopharmacol 8:1320–9
   PubMed Web of Science ®Google Scholar
• Bueno SM, Gonzalez PA, Riedel CA, et al. (2011). Local cytokine response upon respiratory syncytial virus infection. Immunol Lett 136:122–9
   PubMed Web of Science ®Google Scholar
• Casola AN, Burger T, Liu M, et al. (2001). Oxidant tone regulates RANTES gene expression in airway epithelial cells infected with respiratory syncytial virus. Role in viral-induced interferon regulatory factor activation. J Biol Chem 276:19715–22
   PubMed Web of Science ®Google Scholar
• Cayrol C, Girard JP. (2014). IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol 31C:31–7
   Google Scholar
• Cespedes PF, Bueno SM, Ramirez BA, et al. (2014). Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells. Proc Natl Acad Sci USA 111:E3214–23
   PubMed Web of Science ®Google Scholar
• Chang TH, Segovia J, Sabbah A, et al. (2012). Cholesterol-rich lipid rafts are required for release of infectious human respiratory syncytial virus particles. Virology 422:205–13
   PubMed Web of Science ®Google Scholar
• Chen X, Kube DM, Cooper MJ, Davis PB. (2008). Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA. Mol Ther 16:333–42
   PubMed Web of Science ®Google Scholar
• Collins PL, Melero JA. (2011). Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res 162:80–99
   PubMed Web of Science ®Google Scholar
• Correia BE, Bates JT, Loomis RJ, et al. (2014). Proof of principle for epitope-focused vaccine design. Nature 507:201--6
   PubMed Web of Science ®Google Scholar
• Daley D, Park JE, He JQ, et al. (2012). Associations and interactions of genetic polymorphisms in innate immunity genes with early viral infections and susceptibility to asthma and asthma-related phenotypes. J Allergy Clin Immunol 130:1284--93
   Google Scholar
• De Veer MJ, Holko M, Frevel M, et al. (2001). Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 69:912–20
   PubMed Web of Science ®Google Scholar
• Devincenzo JP. (2004). Natural infection of infants with respiratory syncytial virus subgroups A and B: a study of frequency, disease severity, and viral load. Pediatr Res 56:914–17
   PubMed Web of Science ®Google Scholar
• Dewald B, Moser B, Barella L, et al. (1992). IP-10, a gamma-interferon-inducible protein related to interleukin-8, lacks neutrophil activating properties. Immunol Lett 32:81–4
   PubMed Web of Science ®Google Scholar
• Diebold SS, Kaisho T, Hemmi H, et al. (2004). Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529–31
   PubMed Web of Science ®Google Scholar
• Espinoza JA, Bohmwald K, Cespedes PF, et al. (2013). Impaired learning resulting from respiratory syncytial virus infection. Proc Natl Acad Sci USA 110:9112–17
   PubMed Web of Science ®Google Scholar
• Farber JM. (1997). Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 61:246–57
   PubMed Web of Science ®Google Scholar
• Fleming EH, Kolokoltsov AA, Davey RA, et al. (2006). Respiratory syncytial virus F envelope protein associates with lipid rafts without a requirement for other virus proteins. J Virol 80:12160–70
   PubMed Web of Science ®Google Scholar
• Fuentes ME, Durham SK, Swerdel MR, et al. (1995). Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 155:5769–76
   PubMed Web of Science ®Google Scholar
• Gan SW, Ng L, Lin X, et al. (2008). Structure and ion channel activity of the human respiratory syncytial virus (hRSV) small hydrophobic protein transmembrane domain. Protein Sci 17:813–20
   PubMed Web of Science ®Google Scholar
• Garofalo R, Mei F, Espejo R, et al. (1996). Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. J Immunol 157:2506–13
   PubMed Web of Science ®Google Scholar
• Gonzalez PA, Bueno SM, Carreno LJ, et al. (2012). Respiratory syncytial virus infection and immunity. Rev Med Virol 22:230–44
   PubMed Web of Science ®Google Scholar
• Gonzalez PA, Bueno SM, Riedel CA, Kalergis AM. (2009). Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis. Curr Med Chem 16:4609–25
   PubMed Web of Science ®Google Scholar
• Gonzalez PA, Prado CE, Leiva ED, et al. (2008). Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells. Proc Natl Acad Sci USA 105:14999–5004
   PubMed Web of Science ®Google Scholar
• Goritzka M, Durant LR, Pereira C, et al. (2014). Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection. J Virol 88:6128–36
   PubMed Web of Science ®Google Scholar
• Greene CM, Carroll TP, Smith SG, et al. (2005). TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J Immunol 174:1638–46
   PubMed Web of Science ®Google Scholar
• Gu L, Tseng S, Horner RM, et al. (2000). Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404:407–11
   PubMed Web of Science ®Google Scholar
• Gunn MD, Nelken NA, Liao X, Williams LT. (1997). Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J Immunol 158:376–83
   PubMed Web of Science ®Google Scholar
• Guo-Parke H, Canning P, Douglas I, et al. (2013). Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium. Am J Respir Crit Care Med 188:842–51
   PubMed Web of Science ®Google Scholar
• Haberstroh U, Stilo K, Pocock J, et al. (1998). L-arginine suppresses lipopolysaccharide-induced expression of RANTES in glomeruli. J Am Soc Nephrol 9:203–10
   PubMed Web of Science ®Google Scholar
• Han J, Dakhama A, Jia Y, et al. (2012). Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand. J Allergy Clin Immunol 130:1175–1186 e9
   PubMed Web of Science ®Google Scholar
• Holguera J, Villar E, Munoz-Barroso I. (2014). Identification of cellular proteins that interact with Newcastle Disease Virus and human Respiratory Syncytial Virus by a two-dimensional virus overlay protein binding assay (VOPBA). Virus Res 191:138–42
   PubMed Web of Science ®Google Scholar
• Hosakote YM, Liu T, Castro SM, et al. (2009). Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes. Am J Respir Cell Mol Biol 41:348–57
   PubMed Web of Science ®Google Scholar
• Hotard AL, Lee S, Currier MG, et al. (2015). Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis. J Virol 89:512–22
   PubMed Web of Science ®Google Scholar
• Hussman JMA Paes LB, Lanctot KL. (2012). A review of cost-effectiveness of palivizumab for respiratory syncytial virus. Expert Rev Pharmacoecon Outcomes Res 12:553–567
   PubMed Web of Science ®Google Scholar
• Idell S, Kucich U, Fein A, et al. (1985). Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis 132:1098–105
   PubMed Web of Science ®Google Scholar
• Ito T, Wang YH, Duramad O, et al. (2005). TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 202:1213–23
   PubMed Web of Science ®Google Scholar
• Iwane MK, Edwards KM, Szilagyi PG, et al. (2004). Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 113:1758–64
   PubMed Web of Science ®Google Scholar
• Jamaluddin M, Tian B, Boldogh I, et al. (2009). Respiratory syncytial virus infection induces a reactive oxygen species-MSK1-phospho-Ser-276 RelA pathway required for cytokine expression. J Virol 83:10605–15
   PubMed Web of Science ®Google Scholar
• James KM, Peebles Jr RS, Hartert TV. (2012). Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility? J Allergy Clin Immunol 130:343–51
   PubMed Web of Science ®Google Scholar
• Janich P, Corbeil D. (2007). GM1 and GM3 gangliosides highlight distinct lipid microdomains within the apical domain of epithelial cells. FEBS Lett 581:1783–7
   PubMed Web of Science ®Google Scholar
• Jaovisidha P, Peeples ME, Brees AA, et al. (1999). Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release. J Immunol 163:2816–20
   PubMed Web of Science ®Google Scholar
• Jewell NAN, Vaghefi SE, Mertz P, et al. (2007). Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J Virol 81:9790–800
   PubMed Web of Science ®Google Scholar
• Jin H, Cheng X, Traina-Dorge VL, et al. (2003). Evaluation of recombinant respiratory syncytial virus gene deletion mutants in African green monkeys for their potential as live attenuated vaccine candidates. Vaccine 21:3647–52
   PubMed Web of Science ®Google Scholar
• Jin H, Zhou H, Cheng X, et al. (2000). Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2–2 genes are attenuated in vitro and in vivo. Virology 273:210–18
   PubMed Web of Science ®Google Scholar
• Johnson JE, Gonzales RA, Olson SJ, et al. (2007). The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol 20:108–19
   PubMed Web of Science ®Google Scholar
• Johnson TR, Mertz SE, Gitiban N, et al. (2005). Role for innate IFNs in determining respiratory syncytial virus immunopathology. J Immunol 174:7234–41
   PubMed Web of Science ®Google Scholar
• Kaiko GE, Phipps S, Angkasekwinai P, et al. (2010). NK cell deficiency predisposes to viral-induced Th2-type allergic inflammation via epithelial-derived IL-25. J Immunol 185:4681–90
   PubMed Web of Science ®Google Scholar
• Karpus WJ, Lukacs NW, Kennedy KJ, et al. (1997). Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 158:4129–36
   PubMed Web of Science ®Google Scholar
• Kim CK, Kim CS, Park BI, et al. (2003). Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis. J Allergy Clin Immunol 112:64–71
   PubMed Web of Science ®Google Scholar
• Kolli D, Velayutham TS, Casola A. (2013). Host-viral interactions: role of pattern recognition receptors (PRRs) in human pneumovirus infections. Pathogens 2:232--63
   Google Scholar
• Krishnamoorthy N, Khare A, Oriss TB, et al. (2012). Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma. Nat Med 18:1525–30
   PubMed Web of Science ®Google Scholar
• Kristjansson S, Bjarnarson SP, Wennergren G, et al. (2005). Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. J Allergy Clin Immunol 116:805–11
   PubMed Web of Science ®Google Scholar
• Kurihara T, Warr G, Loy J, Bravo R. (1997). Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 186:1757–62
   PubMed Web of Science ®Google Scholar
• Kurt-Jones EA, Popova L, Kwinn L, et al. (2000). Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1:398–401
   PubMed Web of Science ®Google Scholar
• Lambert DM. (1988). Role of oligosaccharides in the structure and function of respiratory syncytial virus glycoproteins. Virology 164:458–66
   PubMed Web of Science ®Google Scholar
• Larranaga CL, Ampuero SL, Luchsinger VF, et al. (2009). Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus. Pediatr Infect Dis J 28:867–73
   PubMed Web of Science ®Google Scholar
• Lay MK, Cespedes PF, Palavecino CE, et al. (2015). Human metapneumovirus infection activates the TSLP pathway which drives excessive pulmonary inflammation and viral replication in mice. Eur J Immunol ; DOI: 10.1002/eji.201445021
   PubMed Web of Science ®Google Scholar
• Lay MK, Gonzalez PA, Leon MA, et al. (2013). Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response. Microbes Infect 15:230–42
   PubMed Web of Science ®Google Scholar
• Lee HC, Headley MB, Loo YM, et al. (2012). Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J Allergy Clin Immunol 130:1187–96 e5
   PubMed Web of Science ®Google Scholar
• Legg JP, Hussain IR, Warner JA, et al. (2003). Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 168:633–9
   PubMed Web of Science ®Google Scholar
• Liang B, Munir S, Amaro-Carambot E, et al. (2014). Chimeric bovine/human parainfluenza virus type 3 expressing RSV F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection. J Virol 88:4237--50
   PubMed Web of Science ®Google Scholar
• Liesman RM, Buchholz UJ, Luongo CL, et al. (2014). RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction. J Clin Invest 124:2219–33
   PubMed Web of Science ®Google Scholar
• Liu P, Jamaluddin M, Li K, et al. (2007). Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J Virol 81:1401–11
   PubMed Web of Science ®Google Scholar
• Liu YJ, Soumelis V, Watanabe N, et al. (2007b). TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 25:193–219
   PubMed Web of Science ®Google Scholar
• Loetscher M, Gerber B, Loetscher P, et al. (1996). Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 184:963–9
   PubMed Web of Science ®Google Scholar
• Luevano M, Daryouzeh M, Alnabhan R, et al. (2012). The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation. Hum Immunol 73:248–57
   PubMed Web of Science ®Google Scholar
• Lukacs NW, Smit JJ, Mukherjee S, et al. (2010). Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation. J Immunol 185:2231–9
   PubMed Web of Science ®Google Scholar
• Marr N, Wang TI, Kam SH, et al. (2014). Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children. J Immunol 192:948–57
   PubMed Web of Science ®Google Scholar
• Mastrangelo P, Hegele RG. (2013). RSV fusion: time for a new model. Viruses 5:873–85
   PubMed Web of Science ®Google Scholar
• Mastronarde JG, He B, Monick MM, et al. (1996). Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-kappa B and NF-IL-6. J Infect Dis 174:262–7
   PubMed Web of Science ®Google Scholar
• Mcintosh K. (1978). Interferon in nasal secretions from infants with viral respiratory tract infections. J Pediatr 93:33–6
   PubMed Web of Science ®Google Scholar
• McLellan JS, Chen M, Joyce MG, et al. (2013). Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342:592–8
   PubMed Web of Science ®Google Scholar
• McNamara PS, Flanagan BF, Hart CA, Smyth RL. (2005). Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 191:1225–32
   PubMed Web of Science ®Google Scholar
• McNamara PS, Flanagan BF, Selby AM, et al. (2004). Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis. Eur Respir J 23:106–12
   PubMed Web of Science ®Google Scholar
• Miazgowicz MM, Elliott MS, Debley JS, Ziegler SF. (2013). Respiratory syncytial virus induces functional thymic stromal lymphopoietin receptor in airway epithelial cells. J Inflamm Res 6:53–61
   PubMedGoogle Scholar
• Miller AL, Strieter RM, Gruber AD, et al. (2003). CXCR2 regulates respiratory syncytial virus-induced airway hyperreactivity and mucus overproduction. J Immunol 170:3348–56
   PubMed Web of Science ®Google Scholar
• Mohapatra SS, Boyapalle S. (2008). Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma. Clin Microbiol Rev 21:495–504
   PubMed Web of Science ®Google Scholar
• Monick MM, Yarovinsky TO, Powers LS, et al. (2003). Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin. J Biol Chem 278:53035–44
   PubMed Web of Science ®Google Scholar
• Monto AS. (2002). Epidemiology of viral respiratory infections. Am J Med 112:4S–12S
   PubMed Web of Science ®Google Scholar
• Morichi SH, Kawashima H, Ioi G, et al. (2011). Classification of acute encephalopathy in respiratory syncytial virus infection. J Infect Chemother 17:776–81
   PubMed Web of Science ®Google Scholar
• Moriyama KY, Takahashi D, Shiihara T. (2014). Another case of respiratory syncytial virus-related limbic encephalitis. Neuroradiology 56:435–6
   PubMed Web of Science ®Google Scholar
• Munir S, Hillyer P, Le Nouen C, et al. (2011). Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. PLoS Pathog 7:e1001336
   PubMed Web of Science ®Google Scholar
• Munir S, Le Nouen C, Luongo C, et al. (2008). Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells. J Virol 82:8780–96
   PubMed Web of Science ®Google Scholar
• Nair H, Nokes DJ, Gessner BD, et al. (2010). Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375:1545–55
   PubMed Web of Science ®Google Scholar
• Neilson KA, Yunis EJ. (1990). Demonstration of respiratory syncytial virus in an autopsy series. Pediatr Pathol 10:491–502
   PubMedGoogle Scholar
• Oshansky CM, Barber JP, Crabtree J, Tripp RA. (2010). Respiratory syncytial virus F and G proteins induce interleukin 1alpha, CC, and CXC chemokine responses by normal human bronchoepithelial cells. J Infect Dis 201:1201–7
   PubMed Web of Science ®Google Scholar
• Oshansky CM, Krunkosky TM, Barber J, et al. (2009). Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway. Viral Immunol 22:147–61
   PubMed Web of Science ®Google Scholar
• Pichlmair A, Schulz O, Tan CP, et al. (2006). RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 314:997–1001
   PubMed Web of Science ®Google Scholar
• Prefontaine D, Lajoie-Kadoch S, Foley S, et al. (2009). Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 183:5094–103
   PubMed Web of Science ®Google Scholar
• Qiao J, Li A, Jin X. (2011). TSLP from RSV-stimulated rat airway epithelial cells activates myeloid dendritic cells. Immunol Cell Biol 89:231–8
   PubMed Web of Science ®Google Scholar
• Reimers K, Buchholz K, Werchau H. (2005). Respiratory syncytial virus M2–1 protein induces the activation of nuclear factor kappa B. Virology 331:260–8
   PubMed Web of Science ®Google Scholar
• Ren T, Wen ZK, Liu ZM, et al. (2007). Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis. Cancer Biol Ther 6:1704–9
   PubMed Web of Science ®Google Scholar
• Robinson RF. (2008). Impact of respiratory syncytial virus in the United States. Am J Health-Syst Pharm 65:S3–6
   PubMed Web of Science ®Google Scholar
• Ruckwardt TJ, Malloy AM, Morabito KM, Graham BS. (2014). Quantitative and qualitative deficits in neonatal lung-migratory dendritic cells impact the generation of the CD8+ T cell response. PLoS Pathog 10:e1003934
   PubMedGoogle Scholar
• Rudan I, O'Brien KL, Nair H, et al. (2013). Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health 3:010401
   PubMed Web of Science ®Google Scholar
• Rudd BD, Burstein E, Duckett CS, et al. (2005). Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol 79:3350–7
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. (1998). Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187:875–83
   PubMed Web of Science ®Google Scholar
• Samuel CE. (2001). Antiviral actions of interferons. Clin Microbiol Rev 14:778–809; table of contents
   PubMed Web of Science ®Google Scholar
• San-Juan-Vergara H, Sampayo-Escobar V, Reyes N, et al. (2012). Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells. J Virol 86:1832–43
   PubMed Web of Science ®Google Scholar
• Semple MG, Dankert HM, Ebrahimi B, et al. (2007). Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P. PLoS One 2:e1038
   PubMedGoogle Scholar
• Shakeri A, Mastrangelo P, Griffin JK, et al. (2014). Respiratory syncytial virus receptor expression in the mouse and viral tropism. Histol Histopathol 30:401--11
   PubMed Web of Science ®Google Scholar
• Shibata T, Habiel DM, Coelho AL, et al. (2014). Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma. J Immunol 192:3569–81
   PubMed Web of Science ®Google Scholar
• Shingai M, Azuma M, Ebihara T, et al. (2008). Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction. Int Immunol 20:1169–80
   PubMed Web of Science ®Google Scholar
• Sigurs N, Aljassim F, Kjellman B, et al. (2010). Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 65:1045–52
   PubMed Web of Science ®Google Scholar
• Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. (2000). Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 161:1501–7
   PubMed Web of Science ®Google Scholar
• Sigurs N, Gustafsson PM, Bjarnason R, et al. (2005). Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 171:137–41
   PubMed Web of Science ®Google Scholar
• Smith DE. (2010). IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin Exp Allergy 40:200–8
   PubMed Web of Science ®Google Scholar
• Soumelis V, Reche PA, Kanzler H, et al. (2002). Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3:673–80
   PubMed Web of Science ®Google Scholar
• Spann KM, Tran KC, Chi B, et al. (2004). Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J Virol 78:4363–9
   PubMed Web of Science ®Google Scholar
• Spann KM, Tran KC, Collins PL. (2005). Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines. J Virol 79:5353–62
   PubMed Web of Science ®Google Scholar
• Stensballe LG, Simonsen JB, Thomsen SF, et al. (2009). The causal direction in the association between respiratory syncytial virus hospitalization and asthma. J Allergy Clin Immunol 123:131–7 e1
   PubMed Web of Science ®Google Scholar
• Stier MT, Goleniewska K, Peebles RS. (2014). Respiratory syncytial virus induces IL-25 and IL-33 production in the lungs. J Allergy Clin Immunol 133:AB53
   Web of Science ®Google Scholar
• Stokes KL, Currier MG, Sakamoto K, et al. (2013). The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection. J Virol 87:10070–82
   PubMed Web of Science ®Google Scholar
• Taub DD, Lloyd AR, Conlon K, et al. (1993). Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 177:1809–14
   PubMed Web of Science ®Google Scholar
• Taub DD, Longo DL, Murphy WJ. (1996). Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues and human peripheral blood lymphocytes-SCID mice. Blood 87:1423–31
   PubMed Web of Science ®Google Scholar
• Taub DD, Sayers TJ, Carter CR, Ortaldo JR. (1995). Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 155:3877–88
   PubMed Web of Science ®Google Scholar
• Taussig LM, Wright AL, Holberg CJ, et al. (2003). Tucson children's respiratory study: 1980 to present. J Allergy Clin Immunol 111:661–75; quiz 676
   PubMed Web of Science ®Google Scholar
• Tayyari F, Marchant D, Moraes TJ, et al. (2011). Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med 17:1132–5
   PubMed Web of Science ®Google Scholar
• Teng MN, Whitehead SS, Collins PL. (2001). Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo. Virology 289:283–96
   PubMed Web of Science ®Google Scholar
• The_IMpact-RSV_Study_Group. (1998). Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102:531–7
   Web of Science ®Google Scholar
• Thomsen SF, van der Sluis S, Stensballe LG, et al. (2009). Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am J Respir Crit Care Med 179:1091–7
   PubMed Web of Science ®Google Scholar
• Velayutham TS, Kolli D, Ivanciuc T, et al. (2013). Critical role of TLR4 in human metapneumovirus mediated innate immune responses and disease pathogenesis. PLoS One 8:e78849
   PubMedGoogle Scholar
• Villenave R, Shields MD, Power UF. (2013). Respiratory syncytial virus interaction with human airway epithelium. Trends Microbiol 21:238–44
   PubMed Web of Science ®Google Scholar
• Villenave R, Thavagnanam S, Sarlang S, et al. (2012). In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc Natl Acad Sci USA 109:5040–5
   PubMed Web of Science ®Google Scholar
• Welliver TP, Garofalo RP, Hosakote Y, et al. (2007). Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 195:1126–36
   PubMed Web of Science ®Google Scholar
• Wu P, Hartert TV. (2011). Evidence for a causal relationship between respiratory syncytial virus infection and asthma. Expert Rev Anti Infect Ther 9:731–45
   PubMed Web of Science ®Google Scholar
• Xie H, Lim YC, Luscinskas FW, Lichtman AH. (1999). Acquisition of selectin binding and peripheral homing properties by CD4(+) and CD8(+) T cells. J Exp Med 189:1765–76
   PubMed Web of Science ®Google Scholar
• Xie XH, Law HK, Wang LJ, et al. (2009). Lipopolysaccharide induces IL-6 production in respiratory syncytial virus-infected airway epithelial cells through the toll-like receptor 4 signaling pathway. Pediatr Res 65:156–62
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Hayashi Y, Sugama Y, et al. (1988). Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med 167:1737–42
   PubMed Web of Science ®Google Scholar
• Zhang L, Peeples ME, Boucher RC, et al. (2002). Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 76:5654–66
   PubMed Web of Science ®Google Scholar
• Zhang L, Bukreyev A, Thompson CI, et al. (2005). Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol 79:1113–24
   PubMed Web of Science ®Google Scholar
• Zhu ZRJ, Homer Z, Wang Q, et al. (1999). Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103:779–88
   PubMed Web of Science ®Google Scholar